Author Correction: Epstein–Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma (Nature Communications, (2015), 6, 1, (7353), 10.1038/ncomms8353);Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma

Nature Communications

Volumn 6, Issue , 2015, Pages

  Cai, Longmei ^a   Ye, Yanfen ^a,b   Jiang, Qiang ^a   Chen, Yuxiang ^a   Lyu, Xiaoming ^a   Li, Jinbang ^a   Wang, Shuang ^a   Liu, Tengfei ^a   Cai, Hongbing ^a   Yao, Kaitai ^a   Li, Ji Liang ^a,c   Li, Xin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FOCAL ADHESION KINASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE B; PROTEIN P130; PROTEIN P53; PROTEIN SHC; UVOMORULIN; VIRUS RNA; MIRN-BART1 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

DISEASE SPREAD; DISEASE TREATMENT; PATHOLOGY; RNA; SENSORY SYSTEM; TUMOR; VIRUS;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER STAGING; CELL INVASION; CELL MIGRATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOSKELETON; DISEASE ASSOCIATION; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NASOPHARYNX CARCINOMA; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REPRODUCIBILITY; RNA SEQUENCE; UPREGULATION; ADULT; ANIMAL; CANCER TRANSPLANTATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HEK293 CELL LINE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; NASOPHARYNX TUMOR; NUDE MOUSE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING;

HUMAN HERPESVIRUS 4;

ADULT; ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SIGNAL TRANSDUCTION;

EID: 84986556391     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-020-17048-0     Document Type: Erratum

References (66)

1. Wei, W. I. & Sham, J. S. Nasopharyngeal carcinoma. Lancet 365, 2041-2054 (2005).
2. Lo, K. W., Chung, G. T. & To, K. F. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin. Cancer Biol. 22, 79-86 (2012).
3. Kutok, J. L. & Wang, F. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1, 375-404 (2006).
4. Tsao, S. W., Tsang, C. M., To, K. F. & Lo, K. W. The role of Epstein-Barr virus in epithelial malignancies. J. Pathol. 235, 323-333 (2015).
5. Marquitz, A. R., Mathur, A., Shair, K. H. & Raab-Traub, N. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proc. Natl Acad. Sci. USA 109, 9593-9598 (2012).
6. Raab-Traub, N. Novel mechanisms of EBV-induced oncogenesis. Curr. Opin. Virol. 2, 453-458 (2012).
7. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
8. Esquela-Kerscher, A. & Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006).
9. Pfeffer, S. et al. Identification of virus-encoded microRNAs. Science 304, 734-736 (2004).
10. Chen, S. J. et al. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS ONE 5, e12745 (2010).
11. Kuzembayeva, M., Hayes, M. & Sugden, B. Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr. Opin. Virol. 7 C, 61-65 (2014).
12. Lo, A. K., Dawson, C. W., Jin, D. Y. & Lo, K. W. The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J. Pathol. 227, 392-403 (2012).
13. Pratt, Z. L., Kuzembayeva, M., Sengupta, S. & Sugden, B. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386, 387-397 (2009).
14. Zeng, Z. et al. Regulation network and expression profiles of Epstein-Barr virusencoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci. China Life Sci. 57, 315-326 (2014).
15. Qiu, J. et al. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog. 7, e1002193 (2011).
16. Marquitz, A. R., Mathur, A., Chugh, P. E., Dittmer, D. P. & Raab-Traub, N. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J. Virol. 88, 1389-1393 (2014).
17. Imig, J. et al. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 39, 1880-1893 (2011).
18. Cosmopoulos, K. et al. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 83, 2357-2367 (2009).
19. Amoroso, R. et al. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J. Virol. 85, 996-1010 (2011).
20. Yang, H. J. et al. Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol. J. 10, 314 (2013).
21. Cai, X. et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2, e23 (2006).
22. Kim do, N. et al. Expression of viral microRNAs in Epstein-Barr virusassociated gastric carcinoma. J. Virol. 81, 1033-1036 (2007).
23. Lo, A. K. et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl Acad. Sci. USA 104, 16164-16169 (2007).
24. Zhu, J. Y. et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J. Virol. 83, 3333-3341 (2009).
25. Choy, E. Y. et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 205, 2551-2560 (2008).
26. Barth, S. et al. Epstein-Barr virus-encoded microRNA miR-BART2 downregulates the viral DNA polymerase BALF5. Nucleic Acids Res. 36, 666-675 (2008).
27. Lung, R. W. et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11, 1174-1184 (2009).
28. Nachmani, D., Stern-Ginossar, N., Sarid, R. & Mandelboim, O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5, 376-385 (2009).
29. Lyu, X. et al. TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol. Cancer 13, 51 (2014).
30. Ye, Y. et al. EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. Biochem. Biophys. Res. Commun. 436, 19-24 (2013).
31. Boyerinas, B., Park, S. M., Hau, A., Murmann, A. E. & Peter, M. E. The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer 17, F19-F36 (2010).
32. Chen, H. C. et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer 100, 1002-1011 (2009).
33. Ouzounova, M. et al. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics 14, 139 (2013).
34. Lu, J. et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 71, 225-233 (2011).
35. Borralho, P. M. et al. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS ONE 6, e23787 (2011).
36. Reid, G. et al. Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Ann. Oncol. 24, 3128-3135 (2013).
37. Cheung, C. C. et al. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Mol. Cancer 13, 184 (2014).
38. Shen, Q. et al. MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. Cancer Lett. 344, 204-211 (2014).
39. Mei, J., Bachoo, R. & Zhang, C. L. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol. Cell. Biol. 31, 3584-3592 (2011).
40. Ito, M. et al. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma. Blood 123, 1499-1511 (2014).
41. Tsuruta, T. et al. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 71, 6450-6462 (2011).
42. Xu, T. et al. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50, 113-121 (2009).
43. Liu, T. et al. An imageable metastatic treatment model of nasopharyngeal carcinoma. Clin. Cancer Res. 13, 3960-3967 (2007).
44. Yang, M. et al. Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc. Natl Acad. Sci. USA 99, 3824-3829 (2002).
45. Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelialmesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196 (2014).
46. Wong, A. M., Kong, K. L., Tsang, J. W., Kwong, D. L. & Guan, X. Y. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118, 698-710 (2012).
47. ∗ microRNA in nasopharyngeal carcinoma. Int. J. Cancer 133, 79-87 (2013).
48. Riley, K. J. et al. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 31, 2207-2221 (2012).
49. Hsu, C. Y. et al. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog. 10, e1003974 (2014).
50. Cai, L. M. et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene (2014).
51. Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403-414 (2008).
52. Song, L. B. et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest. 119, 3626-3636 (2009).
53. Zhang, L. Y. et al. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34, 454-463 (2013).
54. Chen, Q., Samaranayake, L. P., Zhou, H. & Xiao, L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral. Oncol. 36, 95-99 (2000).
55. Qu, C. et al. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 11, 785-796 (2012).
56. Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
57. Zhang, L. et al. microRNA-141 is involved in a nasopharyngeal carcinomarelated genes network. Carcinogenesis 31, 559-566 (2010).
58. Gottwein, E. et al. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10, 515-526 (2011).
59. Yamada, K. M. & Araki, M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci. 114, 2375-2382 (2001).
60. Gu, J. et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J. Cell Biol. 146, 389-403 (1999).
61. Chetram, M. A. & Hinton, C. V. PTEN regulation of ERK1/2 signaling in cancer. J. Recept. Signal. Transduct. Res. 32, 190-195 (2012).
62. Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelialmesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 (2006).
63. Krishna, S. M., Kattoor, J. & Balaram, P. Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark. 1, 271-277 (2005).
64. Liu, S. J. et al. Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Br. J. Cancer 98, 363-369 (2008).
65. Spruck, 3rd C. H. et al. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res. 52, 4787-4790 (1992).
66. Wang, S. et al. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology 53, 1932-1942 (2011).